Global Self-replicating mRNA Vaccines Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
A more common name for self-replicating mRNA is self-amplifying RNA (saRNA). The important difference compared to ordinary mRNA is that it can use its own RNA sequence as a template to replicate itself. Usually mRNA encodes the protein that needs to be expressed, and the ribosomes in the cell are used to complete the translation and protein production. In addition to expressing the target protein, saRNA also carries a sequence that can express RNA polymerase (RNA-dependent RNA polymerase, RdRP). After this RNA polymerase is produced, it can use saRNA as a template to produce more copies of saRNA.
The global Self-replicating mRNA Vaccines market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Self-replicating mRNA Vaccines Industry Forecast” looks at past sales and reviews total world Self-replicating mRNA Vaccines sales in 2023, providing a comprehensive analysis by region and market sector of projected Self-replicating mRNA Vaccines sales for 2024 through 2030. With Self-replicating mRNA Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Self-replicating mRNA Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Self-replicating mRNA Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Self-replicating mRNA Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Self-replicating mRNA Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Self-replicating mRNA Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Self-replicating mRNA Vaccines.
United States market for Self-replicating mRNA Vaccines is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Self-replicating mRNA Vaccines is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Self-replicating mRNA Vaccines is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Self-replicating mRNA Vaccines players cover Chimeron Bio, Ziphius Vaccines, Aldevron, VaxEquity, Precision Nanosystems, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Self-replicating mRNA Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Self-replicating mRNA Vaccines market?
What factors are driving Self-replicating mRNA Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Self-replicating mRNA Vaccines market opportunities vary by end market size?
How does Self-replicating mRNA Vaccines break out by Type, by Application?
A more common name for self-replicating mRNA is self-amplifying RNA (saRNA). The important difference compared to ordinary mRNA is that it can use its own RNA sequence as a template to replicate itself. Usually mRNA encodes the protein that needs to be expressed, and the ribosomes in the cell are used to complete the translation and protein production. In addition to expressing the target protein, saRNA also carries a sequence that can express RNA polymerase (RNA-dependent RNA polymerase, RdRP). After this RNA polymerase is produced, it can use saRNA as a template to produce more copies of saRNA.
The global Self-replicating mRNA Vaccines market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Self-replicating mRNA Vaccines Industry Forecast” looks at past sales and reviews total world Self-replicating mRNA Vaccines sales in 2023, providing a comprehensive analysis by region and market sector of projected Self-replicating mRNA Vaccines sales for 2024 through 2030. With Self-replicating mRNA Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Self-replicating mRNA Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Self-replicating mRNA Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Self-replicating mRNA Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Self-replicating mRNA Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Self-replicating mRNA Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Self-replicating mRNA Vaccines.
United States market for Self-replicating mRNA Vaccines is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Self-replicating mRNA Vaccines is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Self-replicating mRNA Vaccines is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Self-replicating mRNA Vaccines players cover Chimeron Bio, Ziphius Vaccines, Aldevron, VaxEquity, Precision Nanosystems, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Self-replicating mRNA Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Preventive Medicine
- Medicine
- Infectious Disease
- Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Chimeron Bio
- Ziphius Vaccines
- Aldevron
- VaxEquity
- Precision Nanosystems
- Replicate Bioscience
- Elixirgen Therapeutics
- Immorna
- CSL
- Arcturus Therapeutics
- BioNTech
- GSK
- Gritstone Bio
What is the 10-year outlook for the global Self-replicating mRNA Vaccines market?
What factors are driving Self-replicating mRNA Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Self-replicating mRNA Vaccines market opportunities vary by end market size?
How does Self-replicating mRNA Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Self-replicating mRNA Vaccines Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Self-replicating mRNA Vaccines by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Self-replicating mRNA Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Self-replicating mRNA Vaccines Segment by Type
2.2.1 Preventive Medicine
2.2.2 Medicine
2.3 Self-replicating mRNA Vaccines Sales by Type
2.3.1 Global Self-replicating mRNA Vaccines Sales Market Share by Type (2019-2024)
2.3.2 Global Self-replicating mRNA Vaccines Revenue and Market Share by Type (2019-2024)
2.3.3 Global Self-replicating mRNA Vaccines Sale Price by Type (2019-2024)
2.4 Self-replicating mRNA Vaccines Segment by Application
2.4.1 Infectious Disease
2.4.2 Cancer
2.4.3 Others
2.5 Self-replicating mRNA Vaccines Sales by Application
2.5.1 Global Self-replicating mRNA Vaccines Sale Market Share by Application (2019-2024)
2.5.2 Global Self-replicating mRNA Vaccines Revenue and Market Share by Application (2019-2024)
2.5.3 Global Self-replicating mRNA Vaccines Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Self-replicating mRNA Vaccines Breakdown Data by Company
3.1.1 Global Self-replicating mRNA Vaccines Annual Sales by Company (2019-2024)
3.1.2 Global Self-replicating mRNA Vaccines Sales Market Share by Company (2019-2024)
3.2 Global Self-replicating mRNA Vaccines Annual Revenue by Company (2019-2024)
3.2.1 Global Self-replicating mRNA Vaccines Revenue by Company (2019-2024)
3.2.2 Global Self-replicating mRNA Vaccines Revenue Market Share by Company (2019-2024)
3.3 Global Self-replicating mRNA Vaccines Sale Price by Company
3.4 Key Manufacturers Self-replicating mRNA Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Self-replicating mRNA Vaccines Product Location Distribution
3.4.2 Players Self-replicating mRNA Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SELF-REPLICATING MRNA VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Self-replicating mRNA Vaccines Market Size by Geographic Region (2019-2024)
4.1.1 Global Self-replicating mRNA Vaccines Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Self-replicating mRNA Vaccines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Self-replicating mRNA Vaccines Market Size by Country/Region (2019-2024)
4.2.1 Global Self-replicating mRNA Vaccines Annual Sales by Country/Region (2019-2024)
4.2.2 Global Self-replicating mRNA Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Self-replicating mRNA Vaccines Sales Growth
4.4 APAC Self-replicating mRNA Vaccines Sales Growth
4.5 Europe Self-replicating mRNA Vaccines Sales Growth
4.6 Middle East & Africa Self-replicating mRNA Vaccines Sales Growth
5 AMERICAS
5.1 Americas Self-replicating mRNA Vaccines Sales by Country
5.1.1 Americas Self-replicating mRNA Vaccines Sales by Country (2019-2024)
5.1.2 Americas Self-replicating mRNA Vaccines Revenue by Country (2019-2024)
5.2 Americas Self-replicating mRNA Vaccines Sales by Type (2019-2024)
5.3 Americas Self-replicating mRNA Vaccines Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Self-replicating mRNA Vaccines Sales by Region
6.1.1 APAC Self-replicating mRNA Vaccines Sales by Region (2019-2024)
6.1.2 APAC Self-replicating mRNA Vaccines Revenue by Region (2019-2024)
6.2 APAC Self-replicating mRNA Vaccines Sales by Type (2019-2024)
6.3 APAC Self-replicating mRNA Vaccines Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Self-replicating mRNA Vaccines by Country
7.1.1 Europe Self-replicating mRNA Vaccines Sales by Country (2019-2024)
7.1.2 Europe Self-replicating mRNA Vaccines Revenue by Country (2019-2024)
7.2 Europe Self-replicating mRNA Vaccines Sales by Type (2019-2024)
7.3 Europe Self-replicating mRNA Vaccines Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Self-replicating mRNA Vaccines by Country
8.1.1 Middle East & Africa Self-replicating mRNA Vaccines Sales by Country (2019-2024)
8.1.2 Middle East & Africa Self-replicating mRNA Vaccines Revenue by Country (2019-2024)
8.2 Middle East & Africa Self-replicating mRNA Vaccines Sales by Type (2019-2024)
8.3 Middle East & Africa Self-replicating mRNA Vaccines Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Self-replicating mRNA Vaccines
10.3 Manufacturing Process Analysis of Self-replicating mRNA Vaccines
10.4 Industry Chain Structure of Self-replicating mRNA Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Self-replicating mRNA Vaccines Distributors
11.3 Self-replicating mRNA Vaccines Customer
12 WORLD FORECAST REVIEW FOR SELF-REPLICATING MRNA VACCINES BY GEOGRAPHIC REGION
12.1 Global Self-replicating mRNA Vaccines Market Size Forecast by Region
12.1.1 Global Self-replicating mRNA Vaccines Forecast by Region (2025-2030)
12.1.2 Global Self-replicating mRNA Vaccines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Self-replicating mRNA Vaccines Forecast by Type (2025-2030)
12.7 Global Self-replicating mRNA Vaccines Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Chimeron Bio
13.1.1 Chimeron Bio Company Information
13.1.2 Chimeron Bio Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.1.3 Chimeron Bio Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Chimeron Bio Main Business Overview
13.1.5 Chimeron Bio Latest Developments
13.2 Ziphius Vaccines
13.2.1 Ziphius Vaccines Company Information
13.2.2 Ziphius Vaccines Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.2.3 Ziphius Vaccines Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Ziphius Vaccines Main Business Overview
13.2.5 Ziphius Vaccines Latest Developments
13.3 Aldevron
13.3.1 Aldevron Company Information
13.3.2 Aldevron Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.3.3 Aldevron Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Aldevron Main Business Overview
13.3.5 Aldevron Latest Developments
13.4 VaxEquity
13.4.1 VaxEquity Company Information
13.4.2 VaxEquity Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.4.3 VaxEquity Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 VaxEquity Main Business Overview
13.4.5 VaxEquity Latest Developments
13.5 Precision Nanosystems
13.5.1 Precision Nanosystems Company Information
13.5.2 Precision Nanosystems Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.5.3 Precision Nanosystems Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Precision Nanosystems Main Business Overview
13.5.5 Precision Nanosystems Latest Developments
13.6 Replicate Bioscience
13.6.1 Replicate Bioscience Company Information
13.6.2 Replicate Bioscience Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.6.3 Replicate Bioscience Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Replicate Bioscience Main Business Overview
13.6.5 Replicate Bioscience Latest Developments
13.7 Elixirgen Therapeutics
13.7.1 Elixirgen Therapeutics Company Information
13.7.2 Elixirgen Therapeutics Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.7.3 Elixirgen Therapeutics Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Elixirgen Therapeutics Main Business Overview
13.7.5 Elixirgen Therapeutics Latest Developments
13.8 Immorna
13.8.1 Immorna Company Information
13.8.2 Immorna Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.8.3 Immorna Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Immorna Main Business Overview
13.8.5 Immorna Latest Developments
13.9 CSL
13.9.1 CSL Company Information
13.9.2 CSL Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.9.3 CSL Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 CSL Main Business Overview
13.9.5 CSL Latest Developments
13.10 Arcturus Therapeutics
13.10.1 Arcturus Therapeutics Company Information
13.10.2 Arcturus Therapeutics Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.10.3 Arcturus Therapeutics Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Arcturus Therapeutics Main Business Overview
13.10.5 Arcturus Therapeutics Latest Developments
13.11 BioNTech
13.11.1 BioNTech Company Information
13.11.2 BioNTech Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.11.3 BioNTech Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 BioNTech Main Business Overview
13.11.5 BioNTech Latest Developments
13.12 GSK
13.12.1 GSK Company Information
13.12.2 GSK Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.12.3 GSK Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 GSK Main Business Overview
13.12.5 GSK Latest Developments
13.13 Gritstone Bio
13.13.1 Gritstone Bio Company Information
13.13.2 Gritstone Bio Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.13.3 Gritstone Bio Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Gritstone Bio Main Business Overview
13.13.5 Gritstone Bio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Self-replicating mRNA Vaccines Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Self-replicating mRNA Vaccines by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Self-replicating mRNA Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Self-replicating mRNA Vaccines Segment by Type
2.2.1 Preventive Medicine
2.2.2 Medicine
2.3 Self-replicating mRNA Vaccines Sales by Type
2.3.1 Global Self-replicating mRNA Vaccines Sales Market Share by Type (2019-2024)
2.3.2 Global Self-replicating mRNA Vaccines Revenue and Market Share by Type (2019-2024)
2.3.3 Global Self-replicating mRNA Vaccines Sale Price by Type (2019-2024)
2.4 Self-replicating mRNA Vaccines Segment by Application
2.4.1 Infectious Disease
2.4.2 Cancer
2.4.3 Others
2.5 Self-replicating mRNA Vaccines Sales by Application
2.5.1 Global Self-replicating mRNA Vaccines Sale Market Share by Application (2019-2024)
2.5.2 Global Self-replicating mRNA Vaccines Revenue and Market Share by Application (2019-2024)
2.5.3 Global Self-replicating mRNA Vaccines Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Self-replicating mRNA Vaccines Breakdown Data by Company
3.1.1 Global Self-replicating mRNA Vaccines Annual Sales by Company (2019-2024)
3.1.2 Global Self-replicating mRNA Vaccines Sales Market Share by Company (2019-2024)
3.2 Global Self-replicating mRNA Vaccines Annual Revenue by Company (2019-2024)
3.2.1 Global Self-replicating mRNA Vaccines Revenue by Company (2019-2024)
3.2.2 Global Self-replicating mRNA Vaccines Revenue Market Share by Company (2019-2024)
3.3 Global Self-replicating mRNA Vaccines Sale Price by Company
3.4 Key Manufacturers Self-replicating mRNA Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Self-replicating mRNA Vaccines Product Location Distribution
3.4.2 Players Self-replicating mRNA Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SELF-REPLICATING MRNA VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Self-replicating mRNA Vaccines Market Size by Geographic Region (2019-2024)
4.1.1 Global Self-replicating mRNA Vaccines Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Self-replicating mRNA Vaccines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Self-replicating mRNA Vaccines Market Size by Country/Region (2019-2024)
4.2.1 Global Self-replicating mRNA Vaccines Annual Sales by Country/Region (2019-2024)
4.2.2 Global Self-replicating mRNA Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Self-replicating mRNA Vaccines Sales Growth
4.4 APAC Self-replicating mRNA Vaccines Sales Growth
4.5 Europe Self-replicating mRNA Vaccines Sales Growth
4.6 Middle East & Africa Self-replicating mRNA Vaccines Sales Growth
5 AMERICAS
5.1 Americas Self-replicating mRNA Vaccines Sales by Country
5.1.1 Americas Self-replicating mRNA Vaccines Sales by Country (2019-2024)
5.1.2 Americas Self-replicating mRNA Vaccines Revenue by Country (2019-2024)
5.2 Americas Self-replicating mRNA Vaccines Sales by Type (2019-2024)
5.3 Americas Self-replicating mRNA Vaccines Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Self-replicating mRNA Vaccines Sales by Region
6.1.1 APAC Self-replicating mRNA Vaccines Sales by Region (2019-2024)
6.1.2 APAC Self-replicating mRNA Vaccines Revenue by Region (2019-2024)
6.2 APAC Self-replicating mRNA Vaccines Sales by Type (2019-2024)
6.3 APAC Self-replicating mRNA Vaccines Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Self-replicating mRNA Vaccines by Country
7.1.1 Europe Self-replicating mRNA Vaccines Sales by Country (2019-2024)
7.1.2 Europe Self-replicating mRNA Vaccines Revenue by Country (2019-2024)
7.2 Europe Self-replicating mRNA Vaccines Sales by Type (2019-2024)
7.3 Europe Self-replicating mRNA Vaccines Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Self-replicating mRNA Vaccines by Country
8.1.1 Middle East & Africa Self-replicating mRNA Vaccines Sales by Country (2019-2024)
8.1.2 Middle East & Africa Self-replicating mRNA Vaccines Revenue by Country (2019-2024)
8.2 Middle East & Africa Self-replicating mRNA Vaccines Sales by Type (2019-2024)
8.3 Middle East & Africa Self-replicating mRNA Vaccines Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Self-replicating mRNA Vaccines
10.3 Manufacturing Process Analysis of Self-replicating mRNA Vaccines
10.4 Industry Chain Structure of Self-replicating mRNA Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Self-replicating mRNA Vaccines Distributors
11.3 Self-replicating mRNA Vaccines Customer
12 WORLD FORECAST REVIEW FOR SELF-REPLICATING MRNA VACCINES BY GEOGRAPHIC REGION
12.1 Global Self-replicating mRNA Vaccines Market Size Forecast by Region
12.1.1 Global Self-replicating mRNA Vaccines Forecast by Region (2025-2030)
12.1.2 Global Self-replicating mRNA Vaccines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Self-replicating mRNA Vaccines Forecast by Type (2025-2030)
12.7 Global Self-replicating mRNA Vaccines Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Chimeron Bio
13.1.1 Chimeron Bio Company Information
13.1.2 Chimeron Bio Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.1.3 Chimeron Bio Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Chimeron Bio Main Business Overview
13.1.5 Chimeron Bio Latest Developments
13.2 Ziphius Vaccines
13.2.1 Ziphius Vaccines Company Information
13.2.2 Ziphius Vaccines Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.2.3 Ziphius Vaccines Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Ziphius Vaccines Main Business Overview
13.2.5 Ziphius Vaccines Latest Developments
13.3 Aldevron
13.3.1 Aldevron Company Information
13.3.2 Aldevron Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.3.3 Aldevron Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Aldevron Main Business Overview
13.3.5 Aldevron Latest Developments
13.4 VaxEquity
13.4.1 VaxEquity Company Information
13.4.2 VaxEquity Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.4.3 VaxEquity Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 VaxEquity Main Business Overview
13.4.5 VaxEquity Latest Developments
13.5 Precision Nanosystems
13.5.1 Precision Nanosystems Company Information
13.5.2 Precision Nanosystems Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.5.3 Precision Nanosystems Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Precision Nanosystems Main Business Overview
13.5.5 Precision Nanosystems Latest Developments
13.6 Replicate Bioscience
13.6.1 Replicate Bioscience Company Information
13.6.2 Replicate Bioscience Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.6.3 Replicate Bioscience Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Replicate Bioscience Main Business Overview
13.6.5 Replicate Bioscience Latest Developments
13.7 Elixirgen Therapeutics
13.7.1 Elixirgen Therapeutics Company Information
13.7.2 Elixirgen Therapeutics Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.7.3 Elixirgen Therapeutics Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Elixirgen Therapeutics Main Business Overview
13.7.5 Elixirgen Therapeutics Latest Developments
13.8 Immorna
13.8.1 Immorna Company Information
13.8.2 Immorna Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.8.3 Immorna Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Immorna Main Business Overview
13.8.5 Immorna Latest Developments
13.9 CSL
13.9.1 CSL Company Information
13.9.2 CSL Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.9.3 CSL Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 CSL Main Business Overview
13.9.5 CSL Latest Developments
13.10 Arcturus Therapeutics
13.10.1 Arcturus Therapeutics Company Information
13.10.2 Arcturus Therapeutics Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.10.3 Arcturus Therapeutics Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Arcturus Therapeutics Main Business Overview
13.10.5 Arcturus Therapeutics Latest Developments
13.11 BioNTech
13.11.1 BioNTech Company Information
13.11.2 BioNTech Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.11.3 BioNTech Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 BioNTech Main Business Overview
13.11.5 BioNTech Latest Developments
13.12 GSK
13.12.1 GSK Company Information
13.12.2 GSK Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.12.3 GSK Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 GSK Main Business Overview
13.12.5 GSK Latest Developments
13.13 Gritstone Bio
13.13.1 Gritstone Bio Company Information
13.13.2 Gritstone Bio Self-replicating mRNA Vaccines Product Portfolios and Specifications
13.13.3 Gritstone Bio Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Gritstone Bio Main Business Overview
13.13.5 Gritstone Bio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Self-replicating mRNA Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Self-replicating mRNA Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Preventive Medicine
Table 4. Major Players of Medicine
Table 5. Global Self-replicating mRNA Vaccines Sales by Type (2019-2024) & (K Units)
Table 6. Global Self-replicating mRNA Vaccines Sales Market Share by Type (2019-2024)
Table 7. Global Self-replicating mRNA Vaccines Revenue by Type (2019-2024) & ($ million)
Table 8. Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2019-2024)
Table 9. Global Self-replicating mRNA Vaccines Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Self-replicating mRNA Vaccines Sale by Application (2019-2024) & (K Units)
Table 11. Global Self-replicating mRNA Vaccines Sale Market Share by Application (2019-2024)
Table 12. Global Self-replicating mRNA Vaccines Revenue by Application (2019-2024) & ($ million)
Table 13. Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2019-2024)
Table 14. Global Self-replicating mRNA Vaccines Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Self-replicating mRNA Vaccines Sales by Company (2019-2024) & (K Units)
Table 16. Global Self-replicating mRNA Vaccines Sales Market Share by Company (2019-2024)
Table 17. Global Self-replicating mRNA Vaccines Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Self-replicating mRNA Vaccines Revenue Market Share by Company (2019-2024)
Table 19. Global Self-replicating mRNA Vaccines Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Self-replicating mRNA Vaccines Producing Area Distribution and Sales Area
Table 21. Players Self-replicating mRNA Vaccines Products Offered
Table 22. Self-replicating mRNA Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Self-replicating mRNA Vaccines Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Self-replicating mRNA Vaccines Sales Market Share Geographic Region (2019-2024)
Table 27. Global Self-replicating mRNA Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Self-replicating mRNA Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Self-replicating mRNA Vaccines Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Self-replicating mRNA Vaccines Sales Market Share by Country/Region (2019-2024)
Table 31. Global Self-replicating mRNA Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Self-replicating mRNA Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Self-replicating mRNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 34. Americas Self-replicating mRNA Vaccines Sales Market Share by Country (2019-2024)
Table 35. Americas Self-replicating mRNA Vaccines Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Self-replicating mRNA Vaccines Sales by Type (2019-2024) & (K Units)
Table 37. Americas Self-replicating mRNA Vaccines Sales by Application (2019-2024) & (K Units)
Table 38. APAC Self-replicating mRNA Vaccines Sales by Region (2019-2024) & (K Units)
Table 39. APAC Self-replicating mRNA Vaccines Sales Market Share by Region (2019-2024)
Table 40. APAC Self-replicating mRNA Vaccines Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Self-replicating mRNA Vaccines Sales by Type (2019-2024) & (K Units)
Table 42. APAC Self-replicating mRNA Vaccines Sales by Application (2019-2024) & (K Units)
Table 43. Europe Self-replicating mRNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 44. Europe Self-replicating mRNA Vaccines Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Self-replicating mRNA Vaccines Sales by Type (2019-2024) & (K Units)
Table 46. Europe Self-replicating mRNA Vaccines Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa Self-replicating mRNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa Self-replicating mRNA Vaccines Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Self-replicating mRNA Vaccines Sales by Type (2019-2024) & (K Units)
Table 50. Middle East & Africa Self-replicating mRNA Vaccines Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Self-replicating mRNA Vaccines
Table 52. Key Market Challenges & Risks of Self-replicating mRNA Vaccines
Table 53. Key Industry Trends of Self-replicating mRNA Vaccines
Table 54. Self-replicating mRNA Vaccines Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Self-replicating mRNA Vaccines Distributors List
Table 57. Self-replicating mRNA Vaccines Customer List
Table 58. Global Self-replicating mRNA Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 59. Global Self-replicating mRNA Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Self-replicating mRNA Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 61. Americas Self-replicating mRNA Vaccines Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Self-replicating mRNA Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 63. APAC Self-replicating mRNA Vaccines Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Self-replicating mRNA Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Europe Self-replicating mRNA Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Self-replicating mRNA Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa Self-replicating mRNA Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Self-replicating mRNA Vaccines Sales Forecast by Type (2025-2030) & (K Units)
Table 69. Global Self-replicating mRNA Vaccines Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Self-replicating mRNA Vaccines Sales Forecast by Application (2025-2030) & (K Units)
Table 71. Global Self-replicating mRNA Vaccines Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Chimeron Bio Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 73. Chimeron Bio Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 74. Chimeron Bio Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Chimeron Bio Main Business
Table 76. Chimeron Bio Latest Developments
Table 77. Ziphius Vaccines Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. Ziphius Vaccines Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 79. Ziphius Vaccines Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Ziphius Vaccines Main Business
Table 81. Ziphius Vaccines Latest Developments
Table 82. Aldevron Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. Aldevron Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 84. Aldevron Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Aldevron Main Business
Table 86. Aldevron Latest Developments
Table 87. VaxEquity Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. VaxEquity Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 89. VaxEquity Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. VaxEquity Main Business
Table 91. VaxEquity Latest Developments
Table 92. Precision Nanosystems Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Precision Nanosystems Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 94. Precision Nanosystems Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Precision Nanosystems Main Business
Table 96. Precision Nanosystems Latest Developments
Table 97. Replicate Bioscience Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Replicate Bioscience Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 99. Replicate Bioscience Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Replicate Bioscience Main Business
Table 101. Replicate Bioscience Latest Developments
Table 102. Elixirgen Therapeutics Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Elixirgen Therapeutics Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 104. Elixirgen Therapeutics Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Elixirgen Therapeutics Main Business
Table 106. Elixirgen Therapeutics Latest Developments
Table 107. Immorna Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Immorna Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 109. Immorna Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Immorna Main Business
Table 111. Immorna Latest Developments
Table 112. CSL Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. CSL Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 114. CSL Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. CSL Main Business
Table 116. CSL Latest Developments
Table 117. Arcturus Therapeutics Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. Arcturus Therapeutics Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 119. Arcturus Therapeutics Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Arcturus Therapeutics Main Business
Table 121. Arcturus Therapeutics Latest Developments
Table 122. BioNTech Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. BioNTech Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 124. BioNTech Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. BioNTech Main Business
Table 126. BioNTech Latest Developments
Table 127. GSK Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. GSK Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 129. GSK Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. GSK Main Business
Table 131. GSK Latest Developments
Table 132. Gritstone Bio Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Gritstone Bio Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 134. Gritstone Bio Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Gritstone Bio Main Business
Table 136. Gritstone Bio Latest Developments
Table 1. Self-replicating mRNA Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Self-replicating mRNA Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Preventive Medicine
Table 4. Major Players of Medicine
Table 5. Global Self-replicating mRNA Vaccines Sales by Type (2019-2024) & (K Units)
Table 6. Global Self-replicating mRNA Vaccines Sales Market Share by Type (2019-2024)
Table 7. Global Self-replicating mRNA Vaccines Revenue by Type (2019-2024) & ($ million)
Table 8. Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2019-2024)
Table 9. Global Self-replicating mRNA Vaccines Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Self-replicating mRNA Vaccines Sale by Application (2019-2024) & (K Units)
Table 11. Global Self-replicating mRNA Vaccines Sale Market Share by Application (2019-2024)
Table 12. Global Self-replicating mRNA Vaccines Revenue by Application (2019-2024) & ($ million)
Table 13. Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2019-2024)
Table 14. Global Self-replicating mRNA Vaccines Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Self-replicating mRNA Vaccines Sales by Company (2019-2024) & (K Units)
Table 16. Global Self-replicating mRNA Vaccines Sales Market Share by Company (2019-2024)
Table 17. Global Self-replicating mRNA Vaccines Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Self-replicating mRNA Vaccines Revenue Market Share by Company (2019-2024)
Table 19. Global Self-replicating mRNA Vaccines Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Self-replicating mRNA Vaccines Producing Area Distribution and Sales Area
Table 21. Players Self-replicating mRNA Vaccines Products Offered
Table 22. Self-replicating mRNA Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Self-replicating mRNA Vaccines Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Self-replicating mRNA Vaccines Sales Market Share Geographic Region (2019-2024)
Table 27. Global Self-replicating mRNA Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Self-replicating mRNA Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Self-replicating mRNA Vaccines Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Self-replicating mRNA Vaccines Sales Market Share by Country/Region (2019-2024)
Table 31. Global Self-replicating mRNA Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Self-replicating mRNA Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Self-replicating mRNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 34. Americas Self-replicating mRNA Vaccines Sales Market Share by Country (2019-2024)
Table 35. Americas Self-replicating mRNA Vaccines Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Self-replicating mRNA Vaccines Sales by Type (2019-2024) & (K Units)
Table 37. Americas Self-replicating mRNA Vaccines Sales by Application (2019-2024) & (K Units)
Table 38. APAC Self-replicating mRNA Vaccines Sales by Region (2019-2024) & (K Units)
Table 39. APAC Self-replicating mRNA Vaccines Sales Market Share by Region (2019-2024)
Table 40. APAC Self-replicating mRNA Vaccines Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Self-replicating mRNA Vaccines Sales by Type (2019-2024) & (K Units)
Table 42. APAC Self-replicating mRNA Vaccines Sales by Application (2019-2024) & (K Units)
Table 43. Europe Self-replicating mRNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 44. Europe Self-replicating mRNA Vaccines Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Self-replicating mRNA Vaccines Sales by Type (2019-2024) & (K Units)
Table 46. Europe Self-replicating mRNA Vaccines Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa Self-replicating mRNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa Self-replicating mRNA Vaccines Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Self-replicating mRNA Vaccines Sales by Type (2019-2024) & (K Units)
Table 50. Middle East & Africa Self-replicating mRNA Vaccines Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Self-replicating mRNA Vaccines
Table 52. Key Market Challenges & Risks of Self-replicating mRNA Vaccines
Table 53. Key Industry Trends of Self-replicating mRNA Vaccines
Table 54. Self-replicating mRNA Vaccines Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Self-replicating mRNA Vaccines Distributors List
Table 57. Self-replicating mRNA Vaccines Customer List
Table 58. Global Self-replicating mRNA Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 59. Global Self-replicating mRNA Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Self-replicating mRNA Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 61. Americas Self-replicating mRNA Vaccines Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Self-replicating mRNA Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 63. APAC Self-replicating mRNA Vaccines Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Self-replicating mRNA Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Europe Self-replicating mRNA Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Self-replicating mRNA Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa Self-replicating mRNA Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Self-replicating mRNA Vaccines Sales Forecast by Type (2025-2030) & (K Units)
Table 69. Global Self-replicating mRNA Vaccines Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Self-replicating mRNA Vaccines Sales Forecast by Application (2025-2030) & (K Units)
Table 71. Global Self-replicating mRNA Vaccines Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Chimeron Bio Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 73. Chimeron Bio Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 74. Chimeron Bio Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Chimeron Bio Main Business
Table 76. Chimeron Bio Latest Developments
Table 77. Ziphius Vaccines Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. Ziphius Vaccines Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 79. Ziphius Vaccines Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Ziphius Vaccines Main Business
Table 81. Ziphius Vaccines Latest Developments
Table 82. Aldevron Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. Aldevron Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 84. Aldevron Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Aldevron Main Business
Table 86. Aldevron Latest Developments
Table 87. VaxEquity Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. VaxEquity Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 89. VaxEquity Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. VaxEquity Main Business
Table 91. VaxEquity Latest Developments
Table 92. Precision Nanosystems Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Precision Nanosystems Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 94. Precision Nanosystems Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Precision Nanosystems Main Business
Table 96. Precision Nanosystems Latest Developments
Table 97. Replicate Bioscience Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Replicate Bioscience Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 99. Replicate Bioscience Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Replicate Bioscience Main Business
Table 101. Replicate Bioscience Latest Developments
Table 102. Elixirgen Therapeutics Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Elixirgen Therapeutics Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 104. Elixirgen Therapeutics Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Elixirgen Therapeutics Main Business
Table 106. Elixirgen Therapeutics Latest Developments
Table 107. Immorna Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Immorna Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 109. Immorna Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Immorna Main Business
Table 111. Immorna Latest Developments
Table 112. CSL Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. CSL Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 114. CSL Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. CSL Main Business
Table 116. CSL Latest Developments
Table 117. Arcturus Therapeutics Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. Arcturus Therapeutics Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 119. Arcturus Therapeutics Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Arcturus Therapeutics Main Business
Table 121. Arcturus Therapeutics Latest Developments
Table 122. BioNTech Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. BioNTech Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 124. BioNTech Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. BioNTech Main Business
Table 126. BioNTech Latest Developments
Table 127. GSK Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. GSK Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 129. GSK Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. GSK Main Business
Table 131. GSK Latest Developments
Table 132. Gritstone Bio Basic Information, Self-replicating mRNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Gritstone Bio Self-replicating mRNA Vaccines Product Portfolios and Specifications
Table 134. Gritstone Bio Self-replicating mRNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Gritstone Bio Main Business
Table 136. Gritstone Bio Latest Developments
LIST OF FIGURES
Figure 1. Picture of Self-replicating mRNA Vaccines
Figure 2. Self-replicating mRNA Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Self-replicating mRNA Vaccines Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Self-replicating mRNA Vaccines Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Self-replicating mRNA Vaccines Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Self-replicating mRNA Vaccines Sales Market Share by Country/Region (2023)
Figure 10. Self-replicating mRNA Vaccines Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Preventive Medicine
Figure 12. Product Picture of Medicine
Figure 13. Global Self-replicating mRNA Vaccines Sales Market Share by Type in 2023
Figure 14. Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2019-2024)
Figure 15. Self-replicating mRNA Vaccines Consumed in Infectious Disease
Figure 16. Global Self-replicating mRNA Vaccines Market: Infectious Disease (2019-2024) & (K Units)
Figure 17. Self-replicating mRNA Vaccines Consumed in Cancer
Figure 18. Global Self-replicating mRNA Vaccines Market: Cancer (2019-2024) & (K Units)
Figure 19. Self-replicating mRNA Vaccines Consumed in Others
Figure 20. Global Self-replicating mRNA Vaccines Market: Others (2019-2024) & (K Units)
Figure 21. Global Self-replicating mRNA Vaccines Sale Market Share by Application (2023)
Figure 22. Global Self-replicating mRNA Vaccines Revenue Market Share by Application in 2023
Figure 23. Self-replicating mRNA Vaccines Sales by Company in 2023 (K Units)
Figure 24. Global Self-replicating mRNA Vaccines Sales Market Share by Company in 2023
Figure 25. Self-replicating mRNA Vaccines Revenue by Company in 2023 ($ millions)
Figure 26. Global Self-replicating mRNA Vaccines Revenue Market Share by Company in 2023
Figure 27. Global Self-replicating mRNA Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Self-replicating mRNA Vaccines Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Self-replicating mRNA Vaccines Sales 2019-2024 (K Units)
Figure 30. Americas Self-replicating mRNA Vaccines Revenue 2019-2024 ($ millions)
Figure 31. APAC Self-replicating mRNA Vaccines Sales 2019-2024 (K Units)
Figure 32. APAC Self-replicating mRNA Vaccines Revenue 2019-2024 ($ millions)
Figure 33. Europe Self-replicating mRNA Vaccines Sales 2019-2024 (K Units)
Figure 34. Europe Self-replicating mRNA Vaccines Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Self-replicating mRNA Vaccines Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Self-replicating mRNA Vaccines Revenue 2019-2024 ($ millions)
Figure 37. Americas Self-replicating mRNA Vaccines Sales Market Share by Country in 2023
Figure 38. Americas Self-replicating mRNA Vaccines Revenue Market Share by Country (2019-2024)
Figure 39. Americas Self-replicating mRNA Vaccines Sales Market Share by Type (2019-2024)
Figure 40. Americas Self-replicating mRNA Vaccines Sales Market Share by Application (2019-2024)
Figure 41. United States Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Self-replicating mRNA Vaccines Sales Market Share by Region in 2023
Figure 46. APAC Self-replicating mRNA Vaccines Revenue Market Share by Region (2019-2024)
Figure 47. APAC Self-replicating mRNA Vaccines Sales Market Share by Type (2019-2024)
Figure 48. APAC Self-replicating mRNA Vaccines Sales Market Share by Application (2019-2024)
Figure 49. China Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 53. India Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Self-replicating mRNA Vaccines Sales Market Share by Country in 2023
Figure 57. Europe Self-replicating mRNA Vaccines Revenue Market Share by Country (2019-2024)
Figure 58. Europe Self-replicating mRNA Vaccines Sales Market Share by Type (2019-2024)
Figure 59. Europe Self-replicating mRNA Vaccines Sales Market Share by Application (2019-2024)
Figure 60. Germany Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 61. France Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Self-replicating mRNA Vaccines Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Self-replicating mRNA Vaccines Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Self-replicating mRNA Vaccines Sales Market Share by Application (2019-2024)
Figure 68. Egypt Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Self-replicating mRNA Vaccines in 2023
Figure 74. Manufacturing Process Analysis of Self-replicating mRNA Vaccines
Figure 75. Industry Chain Structure of Self-replicating mRNA Vaccines
Figure 76. Channels of Distribution
Figure 77. Global Self-replicating mRNA Vaccines Sales Market Forecast by Region (2025-2030)
Figure 78. Global Self-replicating mRNA Vaccines Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Self-replicating mRNA Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Self-replicating mRNA Vaccines Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Self-replicating mRNA Vaccines Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Self-replicating mRNA Vaccines Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Self-replicating mRNA Vaccines
Figure 2. Self-replicating mRNA Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Self-replicating mRNA Vaccines Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Self-replicating mRNA Vaccines Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Self-replicating mRNA Vaccines Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Self-replicating mRNA Vaccines Sales Market Share by Country/Region (2023)
Figure 10. Self-replicating mRNA Vaccines Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Preventive Medicine
Figure 12. Product Picture of Medicine
Figure 13. Global Self-replicating mRNA Vaccines Sales Market Share by Type in 2023
Figure 14. Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2019-2024)
Figure 15. Self-replicating mRNA Vaccines Consumed in Infectious Disease
Figure 16. Global Self-replicating mRNA Vaccines Market: Infectious Disease (2019-2024) & (K Units)
Figure 17. Self-replicating mRNA Vaccines Consumed in Cancer
Figure 18. Global Self-replicating mRNA Vaccines Market: Cancer (2019-2024) & (K Units)
Figure 19. Self-replicating mRNA Vaccines Consumed in Others
Figure 20. Global Self-replicating mRNA Vaccines Market: Others (2019-2024) & (K Units)
Figure 21. Global Self-replicating mRNA Vaccines Sale Market Share by Application (2023)
Figure 22. Global Self-replicating mRNA Vaccines Revenue Market Share by Application in 2023
Figure 23. Self-replicating mRNA Vaccines Sales by Company in 2023 (K Units)
Figure 24. Global Self-replicating mRNA Vaccines Sales Market Share by Company in 2023
Figure 25. Self-replicating mRNA Vaccines Revenue by Company in 2023 ($ millions)
Figure 26. Global Self-replicating mRNA Vaccines Revenue Market Share by Company in 2023
Figure 27. Global Self-replicating mRNA Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Self-replicating mRNA Vaccines Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Self-replicating mRNA Vaccines Sales 2019-2024 (K Units)
Figure 30. Americas Self-replicating mRNA Vaccines Revenue 2019-2024 ($ millions)
Figure 31. APAC Self-replicating mRNA Vaccines Sales 2019-2024 (K Units)
Figure 32. APAC Self-replicating mRNA Vaccines Revenue 2019-2024 ($ millions)
Figure 33. Europe Self-replicating mRNA Vaccines Sales 2019-2024 (K Units)
Figure 34. Europe Self-replicating mRNA Vaccines Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Self-replicating mRNA Vaccines Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Self-replicating mRNA Vaccines Revenue 2019-2024 ($ millions)
Figure 37. Americas Self-replicating mRNA Vaccines Sales Market Share by Country in 2023
Figure 38. Americas Self-replicating mRNA Vaccines Revenue Market Share by Country (2019-2024)
Figure 39. Americas Self-replicating mRNA Vaccines Sales Market Share by Type (2019-2024)
Figure 40. Americas Self-replicating mRNA Vaccines Sales Market Share by Application (2019-2024)
Figure 41. United States Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Self-replicating mRNA Vaccines Sales Market Share by Region in 2023
Figure 46. APAC Self-replicating mRNA Vaccines Revenue Market Share by Region (2019-2024)
Figure 47. APAC Self-replicating mRNA Vaccines Sales Market Share by Type (2019-2024)
Figure 48. APAC Self-replicating mRNA Vaccines Sales Market Share by Application (2019-2024)
Figure 49. China Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 53. India Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Self-replicating mRNA Vaccines Sales Market Share by Country in 2023
Figure 57. Europe Self-replicating mRNA Vaccines Revenue Market Share by Country (2019-2024)
Figure 58. Europe Self-replicating mRNA Vaccines Sales Market Share by Type (2019-2024)
Figure 59. Europe Self-replicating mRNA Vaccines Sales Market Share by Application (2019-2024)
Figure 60. Germany Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 61. France Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Self-replicating mRNA Vaccines Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Self-replicating mRNA Vaccines Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Self-replicating mRNA Vaccines Sales Market Share by Application (2019-2024)
Figure 68. Egypt Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Self-replicating mRNA Vaccines Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Self-replicating mRNA Vaccines in 2023
Figure 74. Manufacturing Process Analysis of Self-replicating mRNA Vaccines
Figure 75. Industry Chain Structure of Self-replicating mRNA Vaccines
Figure 76. Channels of Distribution
Figure 77. Global Self-replicating mRNA Vaccines Sales Market Forecast by Region (2025-2030)
Figure 78. Global Self-replicating mRNA Vaccines Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Self-replicating mRNA Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Self-replicating mRNA Vaccines Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Self-replicating mRNA Vaccines Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Self-replicating mRNA Vaccines Revenue Market Share Forecast by Application (2025-2030)
